Search results
Jan 19, 2022 · Key Facts. One type of dengue vaccine is available for use in areas with risk of dengue in the United States: Dengvaxia® dengue vaccine. Who Should Get a Dengue Vaccine? CDC recommends dengue vaccination for children 9 through 16 years old, but only when they have been previously infected with dengue and living in areas where dengue is common.
Apr 3, 2024 · A dengue vaccine can protect your patients. For Parents. A safe and effective vaccine to prevent dengue is available. Last Reviewed: April 3, 2024. Source: Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD)
Nov 1, 2023 · A dengue vaccine protects 9 to 16 year olds who have had dengue before and live in areas where dengue is common.
May 01, 2019. Español. The U.S. Food and Drug Administration announced today the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue...
In May 2019, Dengvaxia was approved in the United States as the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3 and 4) in people ages nine through 16 who have laboratory-confirmed previous dengue infection and who live in endemic areas.
Apr 20, 2018 · A safe, effective and affordable dengue vaccine against the four strains would represent a major advance for the control of the disease and could be an important tool for reaching the WHO goal of reducing dengue morbidity by at least 25% and mortality by at least 50% by 2020.
The new vaccine is tetravalent, meaning that it is designed to protect against all four dengue viruses, also called serotypes. This is especially important because of the way the immune system responds. A person who develops antibodies against one serotype of dengue virus is protected against only that specific serotype.
